As­traZeneca ex­pands Cana­da R&D work, to add 500 jobs

As­traZeneca will ex­pand its Cana­da R&D foot­print, ex­pand­ing its cen­ter near Toron­to and cre­at­ing a new rare dis­eases re­search cen­ter there with its Alex­ion unit …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER